Dopamine inhibits mitochondrial motility in hippocampal neurons

PloS One
Sigeng ChenDavid B Edelman


The trafficking of mitochondria within neurons is a highly regulated process. In an earlier study, we found that serotonin (5-HT), acting through the 5-HT1A receptor subtype, promotes axonal transport of mitochondria in cultured hippocampal neurons by increasing Akt activity, and consequently decreasing glycogen synthase kinase (GSK3beta) activity. This finding suggests a critical role for neuromodulators in the regulation of mitochondrial trafficking in neurons. In the present study, we investigate the effects of a second important neuromodulator, dopamine, on mitochondrial transport in hippocampal neurons. Here, we show that dopamine, like 5-HT, regulates mitochondrial motility in cultured hippocampal neurons through the Akt-GSK3beta signaling cascade. But, in contrast to the stimulatory effect of 5-HT, administration of exogenous dopamine or bromocriptine, a dopamine 2 receptor (D2R) agonist, caused an inhibition of mitochondrial movement. Moreover, pretreatment with bromocriptine blocked the stimulatory effect of 5-HT on mitochondrial movement. Conversely, in cells pretreated with 5-HT, no further increases in movement were observed after administration of haloperidol, a D2R antagonist. In contrast to the effect of the D2R ...Continue Reading


Aug 22, 2013·American Journal of Respiratory and Critical Care Medicine·Adrián González-LópezGuillermo M Albaiceta
Oct 5, 2013·Human Molecular Genetics·Fumiaki OgawaJ Kirsty Millar
Jun 30, 2011·Journal of Visualized Experiments : JoVE·David B EdelmanSigeng Chen
Oct 13, 2011·Integrative and Comparative Biology·Katharina A Quinlan
Feb 15, 2012·Advances in Nutrition·Stephanie J B FrethamMichael K Georgieff
Feb 5, 2010·Apoptosis : an International Journal on Programmed Cell Death·Hansruedi Büeler
Sep 14, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Hayley B ClayChristine Konradi
May 4, 2010·Bio Systems·István Bókkon, Ram Lakhan Pandey Vimal
Feb 6, 2010·Bio Systems·István BókkonIstván Antal
Dec 17, 2009·Trends in Cell Biology·Andrew F MacAskill, Josef T Kittler
Apr 4, 2009·Experimental Neurology·Qian Cai, Zu-Hang Sheng
Oct 16, 2010·The European Journal of Neuroscience·Andrew F MacAskillJosef T Kittler
Sep 28, 2015·Trends in Biochemical Sciences·Katherine L GibbsGiampietro Schiavo
Mar 7, 2015·Archives of Toxicology·Daniel José BarbosaFélix Carvalho
Jul 6, 2015·Biochimica Et Biophysica Acta·Marta CherubiniSilvia Ginés
May 3, 2012·Biochimica Et Biophysica Acta·Jonathan R Lovas, Xinnan Wang
May 7, 2015·Drugs in R&D·Maria Corena-McLeod
Jan 24, 2015·Experimental Cell Research·Mei-Yao Lin, Zu-Hang Sheng
Jan 18, 2017·Neuroscience and Biobehavioral Reviews·Gerwyn MorrisMichael Berk
Aug 11, 2016·F1000Research·Meredith M Course, Xinnan Wang
Jan 6, 2012·Nature Reviews. Neuroscience·Zu-Hang Sheng, Qian Cai
Jun 4, 2010·PloS One·Sigeng ChenDavid B Edelman
May 11, 2019·Proceedings of the National Academy of Sciences of the United States of America·Sashaina E FanibundaVidita A Vaidya
Jul 14, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alexey P SarapultsevLarisa P Sidorova


Jan 1, 1989·Annual Review of Psychology·R A Wise, P P Rompre
Jan 1, 1994·Pharmacology & Therapeutics·D M Jackson, A Westlind-Danielsson
Jan 1, 1996·Neuropharmacology·M JaberM G Caron
Feb 11, 1998·Physiological Reviews·C MissaleM G Caron
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·M A CurranG P Nolan
Oct 29, 2000·Trends in Neurosciences·C R Gerfen
Nov 3, 2001·Science·Paul Greengard
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sanjay K MistryKathryn L Crossin
Dec 11, 2002·Journal of Neurochemistry·Dorit Ben-Shachar
Sep 12, 2003·Trends in Pharmacological Sciences·Clare BergsonMichael S Lidow
Nov 5, 2003·Biology of the Cell·Sophie CallierPhilippe Vernier
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jean-Martin BeaulieuMarc G Caron
Apr 23, 2004·Trends in Biochemical Sciences·Richard S Jope, Gail V W Johnson
Jul 23, 2004·Current Biology : CB·Sonita R Chada, Peter J Hollenbeck
Sep 21, 2004·Journal of Bioenergetics and Biomembranes·Ian J ReynoldsGordon L Rintoul
Nov 4, 2004·Journal of Receptor and Signal Transduction Research·Kim A NeveHeather Trantham-Davidson
Aug 24, 2005·Antioxidants & Redox Signaling·Patricia A Trimmer, M Kathleen Borland
Oct 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Latha M MalaiyandiIan J Reynolds
Nov 25, 2005·Journal of Cell Science·Peter J Hollenbeck, William M Saxton
Jan 31, 2006·Trends in Neurosciences·Yuri Bozzi, Emiliana Borrelli
Feb 16, 2006·Current Drug Targets·Philippe Tremblay, Pierre Blier
Jun 21, 2006·The International Journal of Neuropsychopharmacology·Jean-Martin Beaulieu
Jan 5, 2007·BMC Neuroscience·Thomas LembergerGünther Schütz
Jan 26, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jean-Martin BeaulieuMarc G Caron
Feb 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jung-Hyuck AhnAngus C Nairn
Mar 7, 2007·Journal of Cellular Biochemistry·Paramita MookherjeeGail V W Johnson
Mar 14, 2007·Trends in Pharmacological Sciences·Jean-Martin BeaulieuMarc G Caron
May 9, 2007·Bioscience Reports·Lucia PetrozziMichelangelo Mancuso
Oct 2, 2007·Molecular and Cellular Neurosciences·Sigeng ChenDavid B Edelman
Oct 4, 2007·Human Molecular Genetics·Bobby Thomas, M Flint Beal
Oct 20, 2007·Traffic·Rebecca L Frederick, Janet M Shaw
Nov 6, 2007·TheScientificWorldJournal·Susan R George, Brian F O'Dowd
Dec 14, 2007·Novartis Foundation Symposium·M Flint Beal
Feb 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqun ZhangPer Svenningsson

Related Concepts

glycogen synthase kinase 3 beta
Biochemical Pathway
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
Subfamily lentivirinae
Presynaptic Terminals
Axonal Transport
Assay OF Haloperidol
Signaling Cascade

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Molecular and Cellular Neurosciences
Sigeng ChenDavid B Edelman
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Packiasamy A R JulietChinnakannu Panneerselvam
© 2020 Meta ULC. All rights reserved